New study checks how well an antibiotic reaches the brain
NCT ID NCT06119061
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how much of the antibiotic telavancin gets into the brain fluid of 20 critically ill patients who have a drain in their head (external ventricular drain). These patients often need strong antibiotics, but it's not clear if telavancin reaches the brain well enough. Researchers will measure drug levels in blood and brain fluid after three doses to better understand how the body processes the drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Telavancin (Vibativ)
What this could lead to
If successful, this study could help doctors know the right dose of telavancin to treat brain infections in critically ill patients.
What could go wrong
This is a very small, early-phase study (20 people) that only measures drug levels, not whether the drug actually works or improves outcomes. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBARACHNOID HEMORRHAGE, ANEURYSMAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40536, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact